RLMDNasdaq CM

Relmada Therapeutics, Inc.

4.59+0.22%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tierC
Alert levelBaseline

Tier and alert level are a summary. Unlock RLMD to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

−5.36%, downReturn · 1w
−11.73%, downReturn · 1m
−36.78%, downReturn · 3m
+635.58%, upReturn · 1y
−42.63%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 34.

RSI (14)34.10, caution readingLower-neutral
MACD / signal-0.28 / -0.30, favorable readingAbove signal line
SMA 505.65, caution readingPrice below
SMA 2005.44, caution readingPrice below
EMA 204.92, caution readingPrice below
ADX (14)38.45Trending
+DI / −DI13.28 / 28.47, caution reading−DI leading
ATR (14)0.27, flagged reading5.9% of price — elevated daily swings
Stochastic %K19.59, flagged readingOversold zone
Bollinger bands (20)4.25 – 5.60Inside bands
ROC (10)2.68, favorable readingPositive over 10 sessions
Trend / momentum impulseMixedTrend and momentum disagree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking RLMD reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock RLMD: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get RLMD + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock RLMD